Sclerostin loop3: a potential target for developing a next generation sclerostin inhibitor for bone anabolic therapy with low cardiovascular concern (Abstract)

Yuanyuan Yu*, Luyao Wang, Shuaijian Ni, Zhenjian Zhuo, Hang Yin Chu, Ning Zhang, Dijie Li, Jin Liu, Aiping Lyu, Bao Ting Zhang, Ge Zhang*

*Corresponding author for this work

Research output: Contribution to journalConference articlepeer-review

Original languageEnglish
Article numberP-657
Pages (from-to)252
Number of pages1
JournalJournal of Bone and Mineral Research
Issue numberS1
Publication statusPublished - Nov 2020
Event2020 Annual Meeting of the American Society for Bone and Mineral Research - Virtual
Duration: 11 Sept 202015 Sept 2020

Cite this